Abstract: Existing salient object detection methods often adopt deeper and wider networks for better performance, resulting in heavy computational burden and slow inference speed. This inspires us to ...
The Pharmaceutical Research and Manufacturers of America (PhRMA) has stated that the ICH M4Q(R2) involves a significant restructuring of the quality section of the Common Technical Document (CTD), ...
M4Q(R2) is a globally harmonized framework for structuring quality information in medicinal product registration applications. The guidance organizes information into Module 2.3 (Quality Overview) and ...
Global consumption of artificial sweeteners (ASs) has risen substantially in recent years. However, their relationship with prostate cancer (PCa) remains poorly characterized. This study investigates ...
Health Canada has updated the organization and document placement for Canadian module 1 to reflect recent changes. This document contains a table outlining the Canadian module 1 sections and ...
This template is an HTML representation of the form and it is not meant to be completed. To request a copy of the fillable form, please contact brdd-cppic_brdd-cppci@hc-sc.gc.ca. [Insert the flow ...
At gene promoters, RNA polymerase II (Pol II) assembles into a preinitiation complex (PIC) which includes the coactivator Mediator. Here, we describe the PIC-Mediator complex from yeast at ...
The oceans are a fundamental source for climate balance, sustainability of resources and life on Earth, therefore society has a strong and pressing interest in maintaining and, where possible, ...
The regulatory requirements of various countries across the globe differ based on the local agencies. One of the primary challenges for authorities is to ensure that the pharmaceutical products are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results